Dopaminergic neurotransmission modulates and influences hippocampal CA1 synaptic plasticity, learning and long-term memory mechanisms. Investigating the mechanisms involved in the slow-onset potentiation induced by the dopamine D1/D5 receptor agonists in hippocampal CA1 region, we have reported recently that it could play a role in regulating synaptic cooperation and competition. We have also shown that a sustained activation of MEK/MAP kinase pathway was involved in the maintenance of this long-lasting potentiation (Shivarama Shetty, Gopinadhan, & Sajikumar, 2016) . However, the molecular aspects of the induction of dopaminergic slow-onset potentiation are not known. Here, we investigated the involvement of MEK/MAPK pathway and Ca
Introduction

Induction mechanism of long-term potentiation (LTP) involves a transient rise in intracellular Ca
2+ that in turn leads to the activation of many protein kinases (Lynch, 2004; Mayford, Siegelbaum, & Kandel, 2012) . These active protein kinases, such as, Ca 2+ / calmodulin-dependent protein kinase II (CaMKII), mitogenactivated protein kinases (MAPKs), protein kinase-A (PKA), Protein kinase-C (PKC) and others link the transient calcium signals to signal transduction mechanisms essential for the expression of LTP (Giese & Mizuno, 2013) . However, the involvement of the kinases in the induction and maintenance mechanisms differs between different types of LTP depending on the nature of the LTP-inducing stimulus and the brain region (Baudry et al., 2015; Lynch, 2004; Mayford et al., 2012) .
The NMDA receptor-dependent LTP in the hippocampal CA1 region is associated with activation of CaMKII as it is blocked by the inhibitors of CaMKII (Malenka et al., 1989; Malinow, Schulman, & Tsien, 1989) . CaMKII remains persistently activated even after the induction of LTP as a result of autophosphorylation at Thr-286 (Fukunaga, Muller, & Miyamoto, 1995; Fukunaga, Stoppini, Miyamoto, & Muller, 1993; Ouyang, Kantor, Harris, Schuman, & Kennedy, 1997 ) and mutation of this site to prevent autophosphorylation leads to impairments in LTP and learning (Giese, Fedorov, Filipkowski, & Silva, 1998) . Further, mice lacking the CaMKII gene also show deficient hippocampal LTP and impaired spatial learning (Silva, Paylor, Wehner, & Tonegawa, 1992; Silva, Stevens, Tonegawa, & Wang, 1992) , and CaMKII inhibitors block the potentiation induced by activation of cAMP pathways (Makhinson, Chotiner, Watson, & O'Dell, 1999) . On the other hand, CaMKII is not involved in the LTP induction during early development (Yasuda, Barth, Stellwagen, & Malenka, 2003) and in certain other hippocampal synapses (Cooke et al., 2006) .the absence of aCaMKII Thr286 autophosphorylation (Villers, Giese, & Ris, 2014) . Therefore, the extent of involvement of CaMKII in the LTP induction and expression could differ with the type of LTP-inducing stimulus.
MAP-kinases ERK1 (p44 MAPK) and ERK2 (p42 MAPK) are one of the key signal integrators in various forms of LTP and its associativity (Shivarama Shetty, Gopinadhan, & Sajikumar, 2016; Sweatt, 2001) and are known to contribute to both local and nuclear mechanisms following a plasticity inducing event [(Reviewed in (Davis & Laroche, 2006) ]. Dopaminergic neurotransmission through D1-like receptors influences protein synthesis-dependent late phase-LTP and long-term memory in the hippocampus (Frey, Matthies, & Reymann, 1991; Hansen & Manahan-Vaughan, 2014; Jay, 2003; Rossato, Bevilaqua, Izquierdo, Medina, & Cammarota, 2009 ). Notably, a synergistic interaction between dopamine D1 receptors and NMDA receptors involves ERK1/2 signaling mechanisms in rat hippocampus (Sarantis, Matsokis, & Angelatou, 2009 ) and application of dopamine to acute hippocampal slices leads to robust activation of ERK2 in CA1 region (Roberson et al., 1999) . However, MAPKs could be differentially involved in the different phases of plasticity as reported in Aplysia (Sharma et al., 2003) .
Interestingly, dopamine or D1/D5 receptor agonists induce a long-lasting, slow-onset potentiation (SOP) in hippocampal CA1 Schaffer collateral synapses (Huang & Kandel, 1995; Navakkode, Sajikumar, & Frey, 2007; Navakkode, Sajikumar, Korte, & Soong, 2012) suggesting that D1/D5 receptor activation may be involved in the mechanisms of tag-setting and expression of synaptic tagging and capture (STC), a widely studied model for associative plasticity (Redondo & Morris, 2011) . We have recently reported that the D1/D5 receptor-mediated potentiation could lead to differential activation of intracellular mechanisms involving sustained activation of MEK/MAPK pathway in a dose-dependent manner and thus influence STC (Shivarama Shetty et al., 2016) . However, whether CaMKs and MAPKs regulate the induction mechanism of dopaminergic potentiation, specifically in a dose-dependent manner, is not known. Here, we have investigated the differential involvement of MAPKs and CaMKs in the induction and maintenance of the D1/D5 receptor agonist-induced potentiation in acute hippocampal slices of adult rats.
Materials and methods
Preparation of hippocampal slices
A total of 143 acute hippocampal slices prepared from eighty 5-7 week old male Wistar rats were used in the study. All animal procedures were approved by the Institutional Animal Care and Use Committee (IACUC) of National University of Singapore and can be produced upon request. Briefly, after anaesthetization using CO 2 , the rats were decapitated and the brains were quickly removed to 4°C artificial cerebrospinal fluid (aCSF)-a modified Krebs-Ringer solution containing the following (in mM): 124 NaCl, 3.7 KCl, 1.2 KH 2 PO 4 , 1 MgSO 4 Á7H 2 O, 2.5 CaCl 2 Á2H 2 O, 24.6 NaHCO 3 , and 10 D-glucose. The pH of aCSF was between 7.3 and 7.4 when bubbled with 95% oxygen and 5% carbon dioxide (carbogen). Right hippocampus was dissected out in the cold (2-4°C) aCSF being continuously bubbled with carbogen. Transverse hippocampal slices of 400 lm thickness were prepared from the right hippocampus using a manual tissue chopper (Stoelting, Wood Dale, Illinois), transferred onto a nylon net in an interface chamber (Scientific Systems Design, Ontario, Canada) and incubated at 32°C at an aCSF flow rate of 1 ml/min and carbogen consumption of 16 l/h. The slices were incubated for at least 3 h before starting the experiments. For more details see (Shetty et al., 2015; Shivarama Shetty et al., 2016) .
Field-potential recordings
Monopolar, lacquer-coated, stainless steel electrodes (AM Systems) were used as stimulating (<1 MX) and recording electrodes (5 MX). Stimulating electrodes were positioned within the stratum radiatum of the CA1 region to stimulate Schaffer collaterals and the field-EPSP responses were recorded with an electrode placed in the CA1 distal apical dendritic region. After the pre-incubation period, an input-output curve (stimulus intensity vs. fEPSP slope) was plotted for each input and the test stimulus intensity was set to obtain a fEPSP slope 40% of the maximal response. The signals were amplified by a differential amplifier, digitized using a CED 1401 analog-to-digital converter (Cambridge Electronic Design, Cambridge, UK) and monitored online with custom-made software. In all experiments, a stable baseline was recorded for at least 30 min before starting the drug treatments. Four 0.2-Hz biphasic, constant current pulses (spaced at 5 s) given every five minutes were used for baseline and post-induction recording and the average slope value from the four sweeps was considered as one repeat while used for plotting. Initial slopes of fEPSPs were expressed as percentages of baseline averages.
Drugs
The D1/D5 receptor agonist SKF-38393 [(±)-1-Phenyl-2,3,4,5-tet rahedro-(1H)-3-benzazapine-7,8-diol hydrochloride] (SKF; #D047, Sigma-Aldrich) was stored as 15-50 mM stock in deionised water at À20°C protected from light. SKF was diluted to final concentration and bath applied to the slices at 1 ml/min flow rate for three 5-min durations with a 5-min interval between each application (Navakkode et al., 2007 (Navakkode et al., , 2012 Shivarama Shetty et al., 2016) .
The CaM kinase inhibitor KN-93 and its inactive analog KN-92 were purchased from Calbiochem (#422708, #422712, #422709) and reconstituted in DMSO to 5-20 mM stock and stored as aliquots at À20°C protected from light. KN-93, at low concentration (1 lM) specifically inhibits CaMKII whereas at a higher concentration (10 lM) inhibits many CaM kinases, including CaMKII and CaMKIV (Redondo et al., 2010) . The MAPK/ERK kinase (MEK) inhibitor U0126 (1,4-diamino-2,3-dicyano-1,4-bis[2-aminophenylthio] butadiene) was purchased from Promega (#V1121), and stored as aliquots of 20 mM stock in DMSO at À20°C.
Just before application, the stocks were diluted to the final concentration in aCSF and bubbled with carbogen. The drugs were protected from light during storage and the bath application was carried out under dark conditions. Whenever the drug stock was prepared in DMSO, the DMSO concentration in the final bathapplication solution was kept below 0.1%, a concentration which has been shown to not affect basal synaptic responses (Navakkode, Sajikumar, & Frey, 2005) .
Data presentation and statistics
The fEPSP slopes per time point were expressed as percentage of average baseline values in each experiment. The timematched, normalized data were averaged across replicate experiments, plotted against time as 'mean ± SEM' and were then subjected to statistical analysis with GraphPad Prism 6.0. Nonparametric tests were used considering the normality violations at small sample numbers. Wilcoxon matched-pairs signed rank test was used when comparisons were made within a group (a post-induction value compared to its own baseline value). Mann-Whitney U test was used for comparisons between groups. Statistical significance was assumed at P < 0.05. ( * P < 0.05; ** P < 0.01; ***
Results
Role of MEK/MAPK pathway in the induction phase of D1/D5 receptor-mediated potentiation
MEK/MAPK pathway can be activated within minutes following a plasticity-inducing stimulus (Davis & Laroche, 2006) . Hence, we investigated whether MEK/MAPK activation during the induction phase is critically involved in the SKF-induced potentiation. We used the inhibitor U0126, which specifically targets the upstream kinases of ERK1/2 called MEKs (MAP2Ks) (Favata et al., 1998) . U0126 potently inhibits both MEK1 and MEK2, and thus prevents the activation of ERK1/2 [(IC 50 of 72 nM for MEK1 and 58 nM for MEK2); (Duncia et al., 1998) ].
Following a stable baseline recording for 30 min, 5 lM U0126 was bath applied and 15 min later, SKF, at the respective concentration, was co-applied in three pulses similar to that of earlier reports (Navakkode et al., 2007 (Navakkode et al., , 2012 Shivarama Shetty et al., 2016) . Application of U0126 was continued for another 15 min after the end of SKF application; thus, U0126 was applied for a total duration of 55 min. Co-application of 5 lM SKF with 5 lM U0126 failed to induce any potentiation ( Fig. 1B ; n = 7). The mean fEPSP slope values were not significantly different from the baseline values at any time-point during the entire period of recording (Wilcoxon test, P > 0.05). The mean potentiation at the end of the recording (100 ± 6%) was significantly less compared to that without the inhibitor treatment [inset in . Collectively, these experiments indicated that MEK activation during the induction phase was crucial for the long-lasting potentiation induced by D1/D5 receptor activation.
Role of CaMKII in the induction phase of D1/D5 receptor-mediated potentiation
To investigate the role of CaMKII in the induction phase of D1/ D5 receptor-mediated potentiation, we made use of the specific inhibitor of the CaM kinases, KN-93. KN-93 is a cell-permeable, potent inhibitor with an IC 50 of 0.37 lM for CaMKII (Sumi et al., 1991) . It has been reported earlier that at a concentration of 1 lM, KN-93 selectively inhibits the activity of CaMKII while sparing other CaM kinases (Ishida, Kameshita, Okuno, Kitani, & Fujisawa, 1995; Redondo et al., 2010) . Therefore, we co-applied 1 lM KN-93 along with the different concentrations of D1/D5 receptor agonist SKF. Following stable baseline recording for 30 min, 1 lM KN-93 was bath applied and 15 min later, SKF, at the respective concentration, was co-applied in three pulses. KN-93 application was continued for another 15 min after the end of SKF application i.e., KN-93 was applied for a total duration of 55 min.
Blocking the CaMKII activity with KN-93 during 5 lM SKF application completely blocked the SKF-induced potentiation ( Fig. 2A ; n = 7). No significant potentiation was observed at any timepoint over the entire recording period (Wilcoxon test, P > 0.05). The mean potentiation at the end of recording was 106 ± 5% (Wilcoxon test, P = 0.218). KN-92 application, however, did not affect the induction or maintenance of the 5 lM SKF-induced potentiation ( Fig. 2B ; n = 6). The mean potentiation at the end of the recording period was 130 ± 4% (Wilcoxon test, P = 0.031). Interestingly, co-application of KN-93 with 10 lM SKF resulted only in a transient potentiation ( Fig. 2C ; n = 7). The potentiation became significantly different from the baseline by 30 min following SKF application (113 ± 3%, Wilcoxon test, P = 0.015). However, the potentiation started decaying gradually after 165 min (111 ± 6%, Wilcoxon test, P = 0.078) and was not significantly different from the baseline values afterwards. The mean potentiation at the end of the recording period was 104 ± 8% (Wilcoxon test, P = 0.468). Application of KN-92 showed no effect on the maintenance of 10 lM SKF-induced potentiation ( Fig. 2D ; n = 6). The potentiation became statistically significant 15 min onwards and maintained for the entire recording period (Wilcoxon test, P = 0.031). Mean potentiation at the end of the recording period was 135 ± 6%, (Wilcoxon test, P = 0.031).
When KN-93 was applied in the above fashion along with 25 lM SKF, the potentiation followed the usual time course and became significantly different from the baseline values 25 min after the start of SKF application ( Fig. 2E ; 113 ± 3%, Wilcoxon test, P = 0.023) and maintained over the entire recording period (133 ± 5%, Wilcoxon test, P = 0.007, n = 8). The magnitude of potentiation was less compared to that observed with KN-92 treatment, which however, was not statistically significant (Mann-Whitney U test, P > 0.05). The potentiation induced by 25 lM SKF was not affected by the application of KN-92 ( Fig. 2F ; n = 7). Mean potentiation at the end of the recording period was 153 ± 12% (Wilcoxon test, P = 0.015). A comparison of the mean potentiation values at the end of the recording period between the different SKF concentration groups with KN-93 and KN-92 treatment is shown in (Fig. 2G) . Together, these results indicate that at weaker D1/D5 receptor activation, CaMKII has a crucial role in the induction of long-lasting forms of plasticity. However, with stronger D1/D5 receptor activation its role appears to be dispensable, possibly due to coincidental activation of many other kinases, the concerted action of which can compensate for the blockade of CaMKII activity.
Role of CaMKII activity in the maintenance phase
Having observed the differential role of CaMKII in the induction phase, we further investigated its involvement in the maintenance phase of the potentiation induced by different concentrations of SKF. Reports on the involvement of persistently active CaMKII in the maintenance phases of LTP have been confounding (Malinow et al., 1989; Feng, 1995; Chen, Otmakhov, Strack, Colbran, & Lisman, 2001; Lengyel et al., 2004 ). Here, we tested whether persistently active CaMKII is involved in the maintenance of D1/D5 receptor-mediated potentiation. As in the previous series of experiments, we made use of the strategy of specific inhibition of CaMKII with 1 lM . Following a stable baseline recording, SKF, at the respective concentration, was applied to the slices as explained in the initial experiments (Fig. 1) . KN-93 (1 lM) was then bath applied from 90 min after the start of SKF application throughout the rest of the recording period. All these experiments were also repeated with KN-92, an inactive analog of KN-93, to rule out any non-specific treatment effects.
Blocking CaMKII activity with KN-93 during the maintenance phase had no effect on 5 lM SKF-induced potentiation ( Fig. 3A; n = 7). The potentiation became significantly different from the baseline slowly by 80 min (113 ± 4%, Wilcoxon test, P = 0.031), remained statistically significant thereafter until the end of the recording (129 ± 3%, Wilcoxon test, P = 0.015). The experiments were repeated with the KN-92 treatment, which showed no non- specific effects ( Fig. 3B ; n = 7) and the potentiation observed was not significantly different from the KN-93 treatment group (Mann-Whitney U test, P > 0.05).
Application of 1 lM KN-93 had no effect on the maintenance of the potentiation induced by 10 lM SKF ( Fig. 3C ; n = 7) and 25 lM SKF ( Fig. 3E ; n = 7). The mean potentiation at the end of the recording period in both the cases was significantly different from the respective baseline values (Wilcoxon test, P < 0.05). Similar potentiation profile was also observed with 1 lM KN-92 treatment ( Fig. 3D ; n = 6 and Fig. 3F ; n = 6) and there was no statistically significant difference between the respective KN-93 and KN-92 treatment groups (Mann-Whitney U test, P > 0.05).
A histogram comparing the mean potentiation at the end of recording period between the different SKF concentration groups with KN-93 and KN-92 treatment is shown in Fig. 3G . Together, these series of experiments showed that a sustained CaMKII activity is not involved in the maintenance phase of the D1/D5 receptormediated potentiation irrespective of the strength of stimulation.
Role of CaM kinase-IV (CaMKIV) in the maintenance phase of D1/ D5 receptor-mediated potentiation
CaMKIV has been reported to take part in the induction of activity-dependent gene transcription and thus contribute to certain forms of transcription and translation dependent plasticity (Bito, Deisseroth, & Tsien, 1996; Kang et al., 2001; Kasahara, Fukunaga, & Miyamoto, 2001; Redondo et al., 2010) . CaMKIV is a nuclear kinase and becomes activated after phosphorylation by CaM kinase kinase (CaMKK) which, in turn, is activated by nuclear calcium entry in response to strong stimulation. The active CaMKIV then phosphorylates and activates CREB, thus leading to transcription of plasticity-related genes (Bito et al., 1996; Kang et al., 2001; Kasahara et al., 2001 ). We were interested to know whether CaM-KIV activation was involved in the maintenance phase of the potentiation induced by SKF. To investigate this, we made use of the CaM kinase inhibitor KN-93 but now at a higher concentration (10 lM), as it has been reported earlier that at this concentration KN-93 effectively inhibits many CaM kinases, including CaMKIV (Redondo et al., 2010) .
The experimental strategy was similar to that followed in Section 3.3 but 10 lM KN-93 was applied starting 90 min after the SKF application and for the rest of the recording period. These experiments were also repeated with the same concentration of the inactive analog KN-92. The slow-onset, long-lasting potentiation observed following 5 lM SKF application was not affected by the 10 lM KN-93 treatment ( Fig. 4A ; n = 7). The potentiation became statistically significant by 75 min after the SKF application (109 ± 4%; Wilcoxon test, P = 0.046) and then lasted over 4 h. The mean potentiation at the end of the recording (130 ± 7% Wilcoxon test, P = 0.015) was similar to that in the KN-92 group ( Fig. 4B ; 131 ± 6%, Wilcoxon test, P = 0.031; n = 6) and when compared between two groups, there was no significant difference in the magnitude of potentiation (Mann-Whitney U test, P > 0.05). Treatment with 10 lM KN-93 had no significant effect on the potentiation induced by 10 lM SKF ( Fig. 4C ; n = 7). The potentiation followed the usual time course becoming significantly different from the baseline by 20 min after SKF application (114 ± 2%, Wilcoxon test, P = 0.031) and maintained at significant levels throughout the rest of the recording period (Wilcoxon test, P > 0.05). The mean fEPSP slope at the end of the recording (134 ± 7% Wilcoxon test, P = 0.015) was similar to that in the KN-92 treatment group ( Fig. 4D ; 135 ± 8%, Wilcoxon test, P = 0.031; n = 6) and there was no significant difference in the magnitude of potentiation when compared between two groups (Mann-Whitney U test, P > 0.05).
Application of 25 lM SKF resulted in a slow-onset long-lasting potentiation that became significantly different from the baseline values 30 min onwards ( Fig. 4E ; 107 ± 2%, Wilcoxon test, P = 0.023; n = 8) and lasted for the entire recording period (270 min; Wilcoxon test, P = 0.007). Though the potentiation in the late phase was not completely blocked by the treatment with KN-93, the magnitude of potentiation was significantly less compared to that observed in the KN-92 treatment group ( Fig. 4F ; n = 6). When compared to the KN-92 treatment group, the potentiation in KN-93 treatment group was significantly reduced 135 min onwards (Mann-Whitney U test, P < 0.05). The mean potentiation at the end of the recording was 131 ± 7% in KN-93 group whereas it was 148 ± 7% in the KN-92 group. There was also a significant difference in the mean potentiation at the end of recording period, between the 25 lM SKF group [see insert in Fig. 1D ; from (Shivarama Shetty et al., 2016) ] and the 10 lM KN-93 treatment group (Mann-Whitney U test, P = 0.043). A histogram comparing the mean potentiation at the end of recording between the different SKF concentration groups with KN-93 and KN-92 treatment is shown in Fig. 4G . Taken together, these results showed that the active CaMKIV-mediated mechanisms contribute synergistically to the maintenance phase of potentiation only with stronger D1/ D5R activation and were not activated by weaker D1/D5R stimulation. A summary of the effects of inhibition of MEKs and CaMKs during the induction and maintenance phase of the D1/D5 receptormediated potentiation are presented in Table 1A and B respectively.
Discussion
The experiments investigating the role of CaM kinases and MEKs in the induction phase of D1/D5 receptor-mediated potentiation revealed that at weaker levels of dopaminergic activation with its agonist (5 lM SKF), inhibiting either of the kinases, CaMKII or MEKs, completely blocked the induction of potentiation. At moderate levels of dopaminergic activation (10 lM SKF), inhibition of either of the kinases blocked the persistence of the potentiation. However, when the dopaminergic activation was sufficiently strong (25 lM SKF), inhibiting CaMKII during induction had no effect on the induced potentiation whereas inhibiting MEKs blocked the late phase. The late-phase mechanisms in this case were gated through MEK activation. When the dopaminergic activation was moderate, potentiation could still be maintained transiently by other active kinases but the expression of late-phase would require active MEK. With weaker D1/D5 receptor activation, a concerted action of these two kinases was necessary for the induction of the potentiation and thus blocking any of them would interfere with the induction. Differential involvement of kinases in different forms of plasticity has been well appreciated (Baudry et al., 2015; Lynch, 2004; Mayford et al., 2012) . Though CaMKII is known to be involved in many forms of LTP in the hippocampus, its role is not ubiquitous to all forms of NMDAR-dependent LTP: CaMKII inhibitors have no effect on the LTP induction in CA1 during early development (Yasuda et al., 2003) and its involvement is minimal in medial perforant path synapses of DG (Cooke et al., 2006) . On the other hand, inhibitors of MEK block theta-induced LTP while sparing tetanusinduced or pairing-induced LTP (Opazo, Watabe, Grant, & O'Dell, 2003) . Further, in some cases, CaMKII might play a role as a part of a parallel cascade involving MAPK and PKA (Cooke et al., 2006) . Such parallel kinase cascades are known to operate in mice at an early age (Wikstrom, Matthews, Roberts, Collingridge, & Bortolotto, 2003) , in the DG of adult mice (Cooke et al., 2006) and in rats (Wu, Rowan, & Anwyl, 2006) . From these studies, two main limbs of such parallel cascades have been identified one involving CaMKII and the other involving PKA/PKC/MAPK.
In our study, we found no significant role for CaMKII activation or for CaMKIV activation in the maintenance phase of the D1/D5 receptor-mediated potentiation. Application of CaMKII inhibitors following LTP induction has been reported to have no effect on LTP (Chen et al., 2001; Ito, Hidaka, & Sugiyama, 1991; Malinow et al., 1989) . Whether the CaMKII enzyme activity is transient or persistent has been met with confounding results (Fukunaga et al., 1995; Lee, Escobedo-Lozoya, Szatmari, & Yasuda, 2009; Lengyel et al., 2004 (Sumi et al., 1991; Vest, O'Leary, Coultrap, Kindy, & Bayer, 2010) ; but no direct inhibitors of the autophosphorylated form are available currently. Therefore, from these results we can only conclude that no persistent reactivation of the enzyme was involved during the maintenance phase. However, on another note, the autophosphorylated CaMKII is suggested to act as a molecular switch (Lisman, 1994) at the transition of early and late phases of LTP and in itself, this mechanism may not be able to sustain the potentiation for long durations [Reviewed by (Giese & Mizuno, 2013) ]. A mutant deficient in threonine-286 autophosphorylation (T286A) (Giese et al., 1998) can still form memory upon massed training, indicating that CaMKII is not absolutely essential for certain forms memory storage (Irvine, von Hertzen, Plattner, & Giese, 2006) . Additionally, no impairment in the storage of contextual fear long-term memory was seen following a post-training blockade of CaMKII activity (Buard et al., 2010) . Thus, CaMKII involvement may be important only in certain forms of plasticity and even in those forms, its activity may be restricted to certain phases.
We also observed that only at stronger dopaminergic activation, inhibition of both CaMKII and CaMKIV during the maintenance phase resulted in a reduction in the magnitude of potentiation though not completely blocking it. This suggests that CaMKIVmediated mechanisms might be involved only with sufficiently stronger stimulation. Here, CaMKIV pathway might act synergistically with MEK/MAPK pathways to induce CREB activation (Wu, Deisseroth, & Tsien, 2001) . Besides, studies using mutant mice lines have suggested that CaMKIV may be necessary for only certain forms of memory, for instance, fear memory but not for spatial memory (Ho et al., 2000; Kang et al., 2001; Wei et al., 2002) . The CaMKK-CaMKIV cascade is more sensitive to nuclear calcium entry (Hardingham, Arnold, & Bading, 2001 ) which might efficiently happen at stronger stimulations.
These results indicate that at substantially weak levels of dopaminergic stimulation, both CaMKII and MEK activation were necessary for the induction of the slow-onset potentiation. At moderate levels of stimulation, however, either one of these kinases alone could maintain the potentiation transiently but a concerted action of both appeared to be necessary for the maintenance of late phase. Interestingly, when the dopaminergic activation was sufficiently stronger, CaMKII mediated mechanisms became dispensable while MEK activation remained necessary, which supports our earlier finding that MEK activation is crucial for D1/D5 receptor-mediated synaptic plasticity in hippocampal CA1 region (Shivarama Shetty et al., 2016) . These results are important in understanding the dopaminergic modulation of hippocampal synaptic plasticity which is involved in long-term memory storage and also implicated in certain cognitive disorders. 
